- Home
- ANTX vs FINW Comparison
ANTX vs FINW Comparison
Compare ANTX & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | FINW |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.7M | 194.4M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANTX | FINW |
|---|---|---|
| Price | $4.45 | $14.67 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 383.9K | 32.7K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | 21.51 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $160.48 |
| Revenue Next Year | N/A | $35.27 |
| P/E Ratio | ★ N/A | $72.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $12.82 |
| 52 Week High | $6.91 | $22.49 |
Technical Indicators
Market Signals| Indicator | ANTX | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 50.71 |
| Support Level | $3.82 | $13.06 |
| Resistance Level | $5.21 | $14.90 |
| Average True Range (ATR) | 0.40 | 0.52 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 0.91 | 48.70 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.